No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Hedge Funds Investors Own a Significant Stake of 38% in Benitec Biopharma Inc. (NASDAQ:BNTC)
H.C. Wainwright Initiates Benitec Biopharma(BNTC.US) With Buy Rating, Announces Target Price $28
Benitec Biopharma Shakes Up Management Team
Benitec Biopharma Names Sophie Mukadam Chief Operating Officer, Effective Jan. 1
Express News | Benitec Biopharma Inc - Megan Boston Confirmed as CFO and Secretary of Benitec Biopharma
Baird Initiates Benitec Biopharma(BNTC.US) With Buy Rating, Announces Target Price $30
Unlock the Full List